NJHRC applauds over-the-counter naloxone decision, calls for more affordable options

Yesterday, the US Food and Drug Administration (FDA) approved the first ever over-the-counter form of naloxone. This approval applies only to the 4mg nasal spray manufactured by Emergent Biosolutions, which is significantly more expensive than other more affordable versions. including intramuscular naloxone. In response, New Jersey Harm Reduction Coalition (NJHRC) released the following statement. Jenna … Read more

NJHRC: Gov. Murphy’s Opioid Announcement Shows Urgency of Harm Reduction Expansion

Earlier today, Governor Murphy announced 3,040 overdose deaths in 2020 and, strikingly, 540 deaths in January-February of 2021, along with his opioid policy proposals for 2021. The proposed policies make critical commitments to increasing the state budget for harm reduction programs by $1 million, expanding naloxone (brand name Narcan) access, and bolstering availability of medication … Read more